Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Astria Therapeutics Inc (NASDAQ: ATXS) closed at $9.00 in the last session, down -1.85% from day before closing price of $9.17. In other words, the price has decreased by -$1.85 from its previous closing price. On the day, 1.13 million shares were traded. ATXS stock price reached its highest trading level at $9.46 during the session, while it also had its lowest trading level at $8.97.
Ratios:
We take a closer look at ATXS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 21.73 and its Current Ratio is at 21.73. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Evercore ISI on March 28, 2023, initiated with a Outperform rating and assigned the stock a target price of $18.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 01 ’24 when Morabito Christopher sold 10,000 shares for $13.59 per share. The transaction valued at 135,939 led to the insider holds 0 shares of the business.
PERCEPTIVE ADVISORS LLC bought 2,481,350 shares of ATXS for $29,999,522 on Feb 01 ’24. The Director now owns 4,873,721 shares after completing the transaction at $12.09 per share. On Jan 29 ’24, another insider, Morabito Christopher, who serves as the Chief Medical Officer of the company, sold 9,200 shares for $11.15 each. As a result, the insider received 102,552 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATXS now has a Market Capitalization of 494217888 and an Enterprise Value of 343250560.
Stock Price History:
Over the past 52 weeks, ATXS has reached a high of $16.90, while it has fallen to a 52-week low of $4.26. The 50-Day Moving Average of the stock is -31.35%, while the 200-Day Moving Average is calculated to be -0.05%.
Shares Statistics:
According to the various share statistics, ATXS traded on average about 1.06M shares per day over the past 3-months and 843930 shares per day over the past 10 days. A total of 54.91M shares are outstanding, with a floating share count of 44.72M. Insiders hold about 18.56% of the company’s shares, while institutions hold 67.39% stake in the company. Shares short for ATXS as of 1713139200 were 5046064 with a Short Ratio of 4.75, compared to 1710460800 on 2012943. Therefore, it implies a Short% of Shares Outstanding of 5046064 and a Short% of Float of 9.55.
Earnings Estimates
Current recommendations for the stock of the company come from 5.0 analysts. On average, analysts expect EPS of -$0.36 for the current quarter, with a high estimate of -$0.31 and a low estimate of -$0.41, while EPS last year was -$0.4. The consensus estimate for the next quarter is -$0.36, with high estimates of -$0.29 and low estimates of -$0.45.
Analysts are recommending an EPS of between -$1.22 and -$1.91 for the fiscal current year, implying an average EPS of -$1.55. EPS for the following year is -$1.74, with 5.0 analysts recommending between -$1.41 and -$2.09.
